UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000036485
Receipt number R000041570
Scientific Title Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks
Date of disclosure of the study information 2019/04/15
Last modified on 2020/04/13 10:25:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the compound supplements on QOL in adult men

Acronym

Effect of the compound supplements on QOL in adult men

Scientific Title

Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks

Scientific Title:Acronym

Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks

Region

Japan


Condition

Condition

Male menopausal symptoms

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in fatigue VAS after ingestion of the supplements for 8 weeks.

Key secondary outcomes

Changes in AMS score anti aging,QOL total blood testosterone and free blood testosteronea after ingestion of the supplements for 8 weeks.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male

Key inclusion criteria

1)Japanese male aged 20 to 75 at the time of informed consent.
2)Subjects who made a visit to outpatient clinic for male menopause and are diagnosed not to need medication for male menopause symptoms.
3) Subjects who need watch and wait and decide to use health food and the like by their own will for the purpose of nutrition support that is insufficient in the diet..
4) Subjects who will intake the compound supplements.

Key exclusion criteria

1)Subjects who are suspected to have serious disease such as digestive, liver, kidney, circulatory, blood, and endocrine disorder or who have the history of these disorders.
2) Subjects who are judged to require testosterone replacement therapy at outpatient clinic
3)Subjects who are judged to require administration of PDE-5 inhibitor at outpatient clinic
4)Subjects who are judged to require the administration of antidepressants or anti-anxiety drug at outpatient clinics
5)Subjects who are currently taking a supplement which contains a same functional substance as the compound supplements
6)Subjects who may cause allergic reactions to foods
7)Subjects who are heavy smoker or heavy user of alcohol
8)Subjects who are judged as unsuitable for the study by the investigator with other reasons.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Yui

Organization

FANCL Corporation

Division name

Research Institute

Zip code

045-820-3569

Address

Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa

TEL

045-820-3659

Email

tsubokawa_masaya@fancl.co.jp


Public contact

Name of contact person

1st name Isao
Middle name
Last name Takehara

Organization

Clinical Support Corpration

Division name

Food Service Division

Zip code

060-0061

Address

12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan

TEL

045-820-3569

Homepage URL


Email

takehara@csc-smo.co.jp


Sponsor or person

Institute

FANCL Corporation

Institute

Department

Personal name



Funding Source

Organization

FANCL Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical corporation Hokubukai beauty hill hospital ethics review committee

Address

No. 61, Maeda, Kiyota-ku, Sapporo, Hokkaido

Tel

011-882-0111

Email

wakimoto@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

45

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 26 Day

Date of IRB

2019 Year 03 Month 20 Day

Anticipated trial start date

2019 Year 04 Month 15 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 04 Month 12 Day

Last modified on

2020 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041570


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name